, /PRNewswire/ -- Kimberly-Clark Corporation (NASDAQ: KMB) is deepening its commitment to advancing essential care for women and girls through four enhanced strategic, charitable partnerships. Through new programs with Baby2Baby, Plan International, Project HOPE, and UNICEF, Kimberly-Clark aims to expand access to life-changing care in Brazil, Peru, China, India, Indonesia, Vietnam, and the United States. Taken together, these partnerships will work to improve the lives of an estimated 24 million women and ...

रेज योर हैंड इफ यू हैव एवर लुक एट अ फोटो ऑफ योरसेल्फ एंड थॉट हु इज दैट पर्सन कीप देम अप नाउ हाउ मेनी ऑफ़ यू हाव हैड दैट मोमेंट व्हाइल होल्डिंग योर सिक्स मंथ ओल्ड बेबी वंडरिंग वेयर दैट पर्सन यू यूज्ड टू बी वेंट आई सी यू आई वाज यू एंड आई ऍम हियर टू टेल यू समथिंग दैट पर्सन यू आर लुकिंग फॉर शी इज नॉट लॉस्ट शी इज अंडर अंडर कंस्ट्रक्शन। आई एम आर्चल सेठी एंड आई वर्क्ड विथ मल्टीपल कॉर्पोरेट जॉब्स एंड आई हैव रन माय ओन बिज़नेस। आई एम अ मदर ऑफ़ टू एंड नाउ अ फिटनेस एंड अ वेलनेस कंटेंट क्रिएटर। एंड टुडे आई एम गोइंग टू शेयर ...

Company Overview - Prickly Pear Health 专注于女性脑部健康医疗支持 [1] - 公司提供基于 AI 驱动的语音助手，帮助 30-50 岁女性应对影响脑部健康的荷尔蒙变化 [1]

Core Insights - Evofem Biosciences emphasizes the importance of access to contraception for health, future, and freedom on World Contraception Day [1] - The company aims to challenge the status quo in women's health by providing innovative, hormone-free contraceptive options [2][3] - Evofem's commitment includes education and awareness campaigns to reduce stigma around women's health issues [3][4] Product Offerings - PHEXXI is highlighted as the first and only hormone-free, on-demand contraceptive vaginal gel, applied before sexual activity [6] - SOLOSEC is an FDA-approved single-dose oral treatment for bacterial vaginosis and trichomoniasis, targeting women and individuals aged 12 and older [7] Company Vision and Initiatives - Evofem is dedicated to breaking barriers and expanding global access to women's health products [4] - The "Say Vagina" initiative has reached millions, aiming to improve health education and confront stigma [3][10]

Core Insights - Daré Bioscience has entered into an agreement with the Gates Foundation to receive up to approximately $499,000 for mentorship and project management support for research projects addressing preeclampsia, a significant unmet need in maternal care [1][2][3] Company Overview - Daré Bioscience is a biopharmaceutical company focused on women's health, aiming to bridge the gap between scientific innovation and practical solutions [1][5] - The company seeks to bring innovative, evidence-based solutions to market that address long-standing unmet needs in women's health, including areas such as contraception, sexual health, and menopause [5] Engagement Details - The engagement with the Gates Foundation will involve providing strategic mentorship and technical guidance to organizations conducting preclinical research on preeclampsia prevention, diagnosis, and treatment [2][3] - Preeclampsia is a leading cause of maternal and infant morbidity and mortality, with approximately 76,000 mothers and 500,000 babies dying from the condition each year [3][4] Strategic Alignment - This initiative aligns with Daré's long-term strategy to lead in women's health areas that have significant needs and limited treatment options [4][5] - The multi-year engagement aims to enhance the impact and sustainability of research funded through the Gates Foundation's Grand Challenges initiative [3][4]

Healthcare Access - One in three (33.33%) women in America have sought care at a Planned Parenthood clinic [1] - One in ten (10%) men in America have sought care at a Planned Parenthood clinic [1] Political Landscape - Conservatives have long desired to defund Planned Parenthood [1] - Defunding Planned Parenthood is becoming a reality [1]

Wealth & Finance - Larry Ellison's net worth increased by over $110 billion [1] Philanthropy & Investment - Melinda French Gates supports a $100 million partnership focused on women's health [1] News & Events - Charlie Kirk passed away at age 31 due to a shooting incident on Wednesday [1]

Alzheimer's Research Advocacy - The Women's Alzheimer's Movement advocates for women's brain research [1] - The movement aims to rectify the narrative around Alzheimer's, which previously lacked focus on women [1] Media Mention - Maria Shriver, founder of The Women's Alzheimer's Movement, was featured in ForbesOver50 [1]

Brand & Advocacy - Halle Berry, actress and founder of Respin, advocates for women's menopausal health [1] - Halle Berry believes fighting for women's health is a legacy worth leaving [1] Media Mention - Forbes featured Halle Berry and her advocacy for women's health in ForbesOver50 [1]

Economic Impact of Neglecting Women's Health - The global economy loses over $1 trillion annually due to lost productivity, absenteeism, and healthcare costs related to women's health [7] - US employers lose over $225 billion annually in healthcare costs, significantly driven by delayed diagnoses and lower quality of care for women [7] - Pharmaceutical companies miss out on billions by having only 4% of their pipelines focused on female-only conditions [8] - Consumer health and technology companies lose hundreds of millions by developing solutions based on male-centric data [9] Systemic Issues in Women's Healthcare - Women's health is often an afterthought, a blind spot ingrained in how healthcare views women [5] - Over 80% of autoimmune disease patients are women, yet nearly all research (92%) is conducted on men [3] - Delays in diagnosing and treating women's health issues lead to significant economic and personal costs [2][3][7] - Traditional tests often overlook biomarkers and hormone fluctuations relevant to women's health [11] Opportunities in Women's Health (Femtech) - Reframing the conversation around women's health presents a significant economic and healthcare opportunity, potentially beyond a $500 billion market [6][10] - Femtech companies are creating innovative solutions designed around the entire life cycle and experiences of women [15] - AI and precision medicine can be used to improve drug development and predict sex-specific drug responses [12] Actions for Improvement - Challenge outdated narratives, question dismissive care, and refuse to downplay symptoms [18] - Policymakers, healthcare leaders, and technologists should ensure comprehensive policies and evaluate product development pipelines [19] - Physicians should advocate for more comprehensive medical training and question outdated diagnostic criteria [19]